{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:55:40Z","timestamp":1781679340238,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.111003","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:24:24Z","timestamp":1781677464000},"source":"Crossref","is-referenced-by-count":0,"title":["An Aggressive Presentation of Anti-melanoma Differentiation-Associated Gene 5 (MDA-5)-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Zamanali","family":"Khakhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreedhi M","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraiya","family":"Manji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed K","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dermatomyositis","author":"Qudsiya Z","year":"2025","unstructured":"Qudsiya Z, Waseem M. Dermatomyositis. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084301","article-title":"Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review","volume":"23","author":"Kamperman RG","year":"2022","unstructured":"Kamperman RG, van der Kooi AJ, de Visser M, Aronica E, Raaphorst J. Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review. Int J Mol Sci. 2022, 23:4301. 10.3390\/ijms23084301","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1179547619855370","article-title":"Dermatomyositis: an acute flare and current treatments","volume":"12","author":"Okogbaa J","year":"2019","unstructured":"Okogbaa J, Batiste L. Dermatomyositis: an acute flare and current treatments. Clin Med Insights Case Rep. 2019, 12:1179547619855370. 10.1177\/1179547619855370","journal-title":"Clin Med Insights Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omae061","article-title":"Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease","volume":"2024","author":"Biddle K","year":"2024","unstructured":"Biddle K, Agaoglu E, Brent G, et al.. Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease. Oxf Med Case Reports. 2024, 2024:omae061. 10.1093\/omcr\/omae061","journal-title":"Oxf Med Case Reports"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, et al.. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology. 2020, 95:e70-8. 10.1212\/WNL.0000000000009727","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato S","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, et al.. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52:1571-6. 10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03485-z","article-title":"Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease","volume":"27","author":"Zhao K","year":"2025","unstructured":"Zhao K, Zhang J, Kong Q, et al.. Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease. Arthritis Res Ther. 2025, 27:32. 10.1186\/s13075-025-03485-z","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-025-01188-7","article-title":"Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis: recent progress in pathophysiology and treatment","volume":"27","author":"Yoshida T","year":"2025","unstructured":"Yoshida T, Nakashima R. Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis: recent progress in pathophysiology and treatment. Curr Rheumatol Rep. 2025, 27:23. 10.1007\/s11926-025-01188-7","journal-title":"Curr Rheumatol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel A","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. 2021, 12:773352. 10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2915-23","article-title":"Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressing interstitial lung disease successfully treated by initiation of combined immunosuppressive therapy plus plasma exchange and subsequently switching tacrolimus to tofacitinib","volume":"63","author":"Yamazoe M","year":"2024","unstructured":"Yamazoe M, Takeda K, Nagano Y, et al.. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressing interstitial lung disease successfully treated by initiation of combined immunosuppressive therapy plus plasma exchange and subsequently switching tacrolimus to tofacitinib. Intern Med. 2024, 63:2571-8. 10.2169\/internalmedicine.2915-23","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.92a.25018","article-title":"MDA5 dermatomyositis: unveiling a potentially life-threatening disease","volume":"92","author":"Chatterjee S","year":"2025","unstructured":"Chatterjee S. MDA5 dermatomyositis: unveiling a potentially life-threatening disease. Cleve Clin J Med. 2025, 92:627-37. 10.3949\/ccjm.92a.25018","journal-title":"Cleve Clin J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta P","year":"2021","unstructured":"Mehta P, Machado PM, Gupta L. Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int. 2021, 41:1021-36. 10.1007\/s00296-021-04819-1","journal-title":"Rheumatol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.18728.1","article-title":"Case Report: anti-MDA-5 dermatomyositis in a resource-limited setting","volume":"8","author":"Risal U","year":"2023","unstructured":"Risal U, Pandey S, Pangeni R, Pandey R, Bhattarai D, Adhikari S, Basnyat B. Case Report: anti-MDA-5 dermatomyositis in a resource-limited setting. Wellcome Open Res. 2023, 8:5. 10.12688\/wellcomeopenres.18728.1","journal-title":"Wellcome Open Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino D","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011, 65:25-34. 10.1016\/j.jaad.2010.09.016","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall JC","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken). 2013, 65:1307-15. 10.1002\/acr.21992","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1628748","article-title":"Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis","volume":"16","author":"Yang Y","year":"2025","unstructured":"Yang Y, Li Y, Yuan W, Zhang S, He X, Ji J. Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2025, 16:1628748. 10.3389\/fimmu.2025.1628748","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0154-4","article-title":"Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?","volume":"15","author":"Ikeda S","year":"2015","unstructured":"Ikeda S, Arita M, Morita M, et al.. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?. BMC Pulm Med. 2015, 15:159. 10.1186\/s12890-015-0154-4","journal-title":"BMC Pulm Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496392-an-aggressive-presentation-of-anti-melanoma-differentiation-associated-gene-5-mda-5-positive-dermatomyositis-with-rapidly-progressive-interstitial-lung-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:24:25Z","timestamp":1781677465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496392-an-aggressive-presentation-of-anti-melanoma-differentiation-associated-gene-5-mda-5-positive-dermatomyositis-with-rapidly-progressive-interstitial-lung-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.111003","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}